Status:

COMPLETED

Influence of Femoral Head Size During Total Hip Arthroplasty on Gait

Lead Sponsor:

Medical University of Warsaw

Conditions:

Osteoarthritis, Hip

Hip Arthritis

Eligibility:

All Genders

60-80 years

Phase:

NA

Brief Summary

Total hip replacement (THR) is being considered as one of the most effective medical procedures. Since its introduction, there was a worldwide debate over proper implant selection in terms of size, be...

Detailed Description

Total hip replacement (THR) is being considered as one of the most effective medical procedures. Since its introduction, there was a worldwide debate over proper implant selection in terms of size, be...

Eligibility Criteria

Inclusion

  • BMI \<35
  • Ability to walk for 10 meters
  • 60-80 years of age
  • Bilateral THR

Exclusion

  • Revision surgeries before and after THR
  • Any other lower limbs surgeries
  • Secondary OA
  • Neurological disorders
  • Cardiac disorders
  • Severly impaired balance
  • Severe dizziness

Key Trial Info

Start Date :

January 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2020

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04521842

Start Date

January 1 2016

End Date

September 1 2020

Last Update

October 14 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Othopedics and Rehabilitation, Medical University of Warsaw

Warsaw, Poland